There is overwhelming evidence that links
maternal nutrition during pregnancy with fetal outcomes. This study evaluated
the safety and efficacy of Protiva treatment responses in pre and postpartum
female subjects between the ages of 19 years and 43 years who entered into this
open label study.
The protocol was designed to take a twice
daily collagen protein supplementation drink during the third trimester and for 10 weeks postpartum. The outcomes were measured against a control
group of patients who did not take the protein supplementation.
The differences between mean score for the
physical health domain of WHOQOL-BREF scale in the Protiva group and the
control group were different and met statistical significance (p=0.0003).
No comments:
Post a Comment